S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 241 to 300 of 539

Issue Date	Title / Author(s) / Citation	File
2011-05	Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer Baek, Sun Kyung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue BMC Gastroenterology, Vol.11, p. 56	DOI
2011-05	Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection Lee, Yun-Gyoo; Han, Sae-Won; Oh, Do-Youn; Chie, Eui Kyu; Jang, Jin-Young; Im, Seock-Ah; Kim, Tae-You; Kim, Sun-Whe; Ha, Sung Whan; Bang, Yung-Jue BMC Cancer, Vol.11, p. 188	DOI
2011-06	The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010 Van Cutsem, E.; Dicato, M.; Geva, R.; Arber, N.; Bang, Y.; Benson, A.; Cervantes, A.; Diaz-Rubio, E.; Ducreux, M.; Glynne-Jones, R.; Grothey, A.; Haller, D.; Haustermans, K.; Kerr, D.; Nordlinger, B.; Marshall, J.; Minsky, B. D.; Kang, Y. K.; Labianca, R.; Lordick, F.; Ohtsu, A.; Pavlidis, N.; Roth, A.; Rougier, P.; Schmoll, H. J.; Sobrero, A.; Tabernero, J.; Van de Velde, C.; Zalcberg, J. Annals of Oncology, Vol.22, pp.v1-v9	DOI
2011-06	Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors Zamboni, William C.; Maruca, Lauren J.; Strychor, Sandra; Zamboni, Beth A.; Ramalingam, Suresh; Edwards, Robert P.; Kim, J. K.; Bang, Y. J.; Lee, H. Y.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Ramanathan, Ramesh K. Journal of Liposome Research, Vol.21 No.2, pp.158-165	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2011-06	Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis Hong, Junshik; Han, Sae-Won; Ham, Hye Seon; Kim, Tae-Yong; Choi, In Sil; Kim, Byung-Su; Oh, Do-Youn; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.67 No.6, pp.1323-1331	DOI
2011-07	RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma Catenacci, Daniel V. T.; Cervantes, Gustavo; Yala, Soheil; Nelson, Erik A.; El-Hashani, Essam; Kanteti, Rajani; El Dinali, Mohamed; Hasina, Rifat; Braegelmann, Johannes; Seiwert, Tanguy; Sanicola, Michele; Henderson, Les; Grushko, Tatyana A.; Olopade, Olufunmilayo; Karrison, Theodore; Bang, Yung-Jue; Kim, Woo Ho; Tretiakova, Maria; Vokes, Everett; Frank, David A.; Kindler, Hedy L.; Huet, Heather; Salgia, Ravi Cancer Biology and Therapy, Vol.12 No.1, pp.9-46	DOI
2011-07	Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175	DOI
2011-07	Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins Lee, Kyung-Hun; Lee, Ju-Hee; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Science, Vol.102 No.7, pp.1388-1395	DOI
2011-08	Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles Kim, Hyo Song; Hong, Min Hee; Kim, Kiyeol; Shin, Sang-Joon; Ahn, Joong-Bae; Jeung, Hei Chul; Chung, Hyun Cheol; Koh, Youngil; Lee, Se-Hoon; Bang, Yung-Jue; Rha, Sun Young Oncology, Vol.80 No.5-6, pp.395-405	DOI
2011-09	Anaplastic Lymphoma Kinase Translocation A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Soyeon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Kim, Woo-Ho; Kim, Young Tae; Yang, Seok-Chul; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Journal of Thoracic Oncology, Vol.6 No.9, pp.1474-1480	DOI
2011-09	Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Park, Sohee; Nam, Byung-Ho; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Heo, Dae Seog; Bang, Yung-Jue Journal of Cancer Research and Clinical Oncology, Vol.137 No.9, pp.1301-1308	DOI
2011-09	VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib Koh, Youngil; Lee, Hee Eun; Im, Seock-Ah; Kim, Se-Hyung; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Tae-You; Kim, Woo-Ho; Heo, Dae Seog; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.3, pp.143-147	DOI
2011-10	Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis Shaw, Alice T.; Yeap, Beow Y.; Solomon, Benjamin J.; Riely, Gregory J.; Gainor, Justin; Engelman, Jeffrey A.; Shapiro, Geoffrey I.; Costa, Daniel B.; Ou, Sai-Hong I.; Butaney, Mohit; Salgia, Ravi; Maki, Robert G.; Varella-Garcia, Marileila; Doebele, Robert C.; Bang, Yung-Jue; Kulig, Kimary; Selaru, Paulina; Tang, Yiyun; Wilner, Keith D.; Kwak, Eunice L.; Clark, Jeffrey W.; Iafrate, A. John; Camidge, D. Ross The Lancet Oncology, Vol.12 No.11, pp.1004-1012	DOI
2011-10	Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting Lim, Kyu-Hyoung; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1017-1026	DOI
2011-10	Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer Park, Jin Hyun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Jeong, Seung-Yong; Park, Kyu Joo; Kim, Tae-You; Bang, Yung-Jue; Park, Jae-Gahb Cancer Chemotherapy and Pharmacology, Vol.68 No.4, pp.1045-1055	DOI
2011-10	Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy Keam, Bhumsuk; Im, Seock-Ah; Koh, Youngil; Han, Sae-Won; Oh, Do-Youn; Cho, Nariya; Kim, Jee Hyun; Han, Wonshik; Kang, Keon Wook; Moon, Woo Kyung; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Chung, June-Key; Bang, Yung-Jue BMC Cancer, Vol.11, p. 452	DOI
2011-11	Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma Kim, Min A.; Lee, Hyuk-Joon; Yang, Han-Kwang; Bang, Yung-Jue; Kim, Woo Ho Histopathology, Vol.59 No.5, pp.822-831	DOI
2011-12	Capecitabine in gastric cancer Bang, Yung-Jue Expert Review of Anticancer Therapy, Vol.11 No.12, pp.1791-1806	DOI
2011-12	Epigenetic-Based Therapies in Cancer Progress to Date Song, Sang-Hyun; Han, Sae-Won; Bang, Yung-Jue Drugs, Vol.71 No.18, pp.2391-2403	DOI
2011-12	Phase II study of sunitinib as second-line treatment for advanced gastric cancer Bang, Yung-Jue; Kang, Yoon-Koo; Kang, Won K.; Boku, Narikazu; Chung, Hyun C.; Chen, Jen-Shi; Doi, Toshihiko; Sun, Yan; Shen, Lin; Qin, Shukui; Ng, Wai-Tong; Tursi, Jennifer M.; Lechuga, Maria J.; Lu, Dongrui Ray; Ruiz-Garcia, Ana; Sobrero, Alberto Investigational New Drugs, Vol.29 No.6, pp.1449-1458	DOI
2011-12	MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib Lennerz, Jochen K.; Kwak, Eunice L.; Ackerman, Allison; Michael, Michael; Fox, Stephen B.; Bergethon, Kristin; Lauwers, Gregory Y.; Christensen, James G.; Wilner, Keith D.; Haber, Daniel A.; Salgia, Ravi; Bang, Yung-Jue; Clark, Jeffrey W.; Solomon, Benjamin J.; Iafrate, A. John Journal of Clinical Oncology, Vol.29 No.36, pp.4803-4810	DOI
2011-12	Capecitabine in gastric cancer Bang, Yung-Jue Expert Review of Anticancer Therapy, Vol.11 No.12, pp.1791-1806	DOI
2012	Postoperative chemoradiotherapy in high risk locally advanced gastric cancer Song, S.; Chie, E.K.; Kim, K.; Lee, H.-J.; Yang, H.-K.; Han, S.-W.; Oh, D.-Y.; Im, S.-A.; Bang, Y.-J.; Ha, S.W. Radiation Oncology Journal, Vol.30 No.4, pp.213-217	DOI
2012-01	Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Bang, Yung-Jue; Kim, Young-Woo; Yang, Han-Kwang; Chung, Hyun Cheol; Park, Young-Kyu; Lee, Kyung Hee; Lee, Keun-Wook; Kim, Yong Ho; Noh, Sang-Ik; Cho, Jae Yong; Mok, Young Jae; Kim, Yeul Hong; Ji, Jiafu; Yeh, Ta-Sen; Button, Peter; Sirzen, Florin; Noh, Sung Hoon The Lancet, Vol.379 No.9813, pp.315-321	DOI
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-02	Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies Wu, Huali; Ramanathan, Ramesh K.; Zamboni, Beth A.; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Maruca, Lauren J.; Bang, Yung-Jue; Zamboni, William C. Journal of Clinical Pharmacology, Vol.52 No.2, pp.180-194	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-02	Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy Kim, Jin Won; Cha, Yongjun; Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Supportive Care in Cancer, Vol.20 No.2, pp.395-403	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Song, Sang-Hyun; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Letters, Vol.316 No.1, pp.77-84	DOI
2012-03	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You PLoS ONE, Vol.7 No.3, p. e0033322	DOI
2012-04	The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen Kim, Jin Won; Im, Seock-Ah; Kim, Miso; Cha, Yongjun; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Anticancer Research, Vol.32 No.4, pp.1547-1553
2012-04	Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study Kang, Hye Jin; Ryu, Min-Hee; Kim, Kyoung-Mee; Park, Young Soo; Choi, Jene; Ryoo, Baek-Yeol; Kim, Woo Ho; Im, Seock-Ah; Bang, Yung-Jue; Park, Se Hoon; Lee, Jae-Hyuk; Chung, Ik Joo; Bae, Han-Ik; Kim, Jong Gwang; Lee, Kyung Hee; Song, Hong Suk; Kwon, Hyuk-Chan; Baek, Jin Ho; Shin, Dong Bok; Lee, Kyoung Eun; Kang, Yoon-Koo Acta Oncologica, Vol.51 No.4, pp.528-536	DOI
2012-04	Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: A long-term single center experience Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.35 No.2, pp.136-140	DOI
2012-04	NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue International Journal of Oncology, Vol.40 No.4, pp.1259-1266	DOI
2012-05	Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Clinical and Translational Oncology, Vol.14 No.5, pp.391-395	DOI
2012-05	Postoperative chemoradiotherapy for gallbladder cancer Kim, K.; Chie, E. K.; Jang, J. -Y.; Kim, S. W.; Han, S. -W.; Oh, D. -Y.; Im, S. -A.; Kim, T. -Y.; Bang, Y. -J.; Ha, S. W. Strahlentherapie und Onkologie, Vol.188 No.5, pp.388-394	DOI
2012-06	A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research Oh, Do-Youn; Lee, Keun Wook; Lee, Kyung-Hee; Sohn, Chang-Hak; Park, Young Suk; Zang, Dae Young; Ryoo, Hun-Mo; Song, Hong-Suk; Kim, Jin-Soo; Kang, Hye-Jin; Kim, Bong-Seog; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.3, pp.1164-1174	DOI
2012-06	Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150	DOI
2012-07	MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H. British Journal of Cancer, Vol.107 No.2, pp.325-333	DOI
2012-07	Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients Wu, Huali; Ramanathan, Ramesh K.; Zamboni, Beth A.; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Maruca, Lauren J.; Bang, Yung-Jue; Zamboni, William C. International journal of nanomedicine, Vol.7, pp.5555-5564	DOI
2012-07	Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer Lee, June Koo; Park, Heae Surng; Kim, Dong-Wan; Kulig, Kimary; Kim, Tae Min; Lee, Se-Hoon; Jeon, Yoon-Kyung; Chung, Doo Hyun; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Cancer, Vol.118 No.14, pp.3579-3586	DOI
2012-07	Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer Lim, Kyu-Hyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncology, Vol.83 No.2, pp.57-66	DOI
2012-07	Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Yun, Jiyeon; Song, Sang-Hyun; Park, Jinah; Kim, Hwang-Phill; Yoon, Young-Kwang; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.92 No.7, pp.1033-1044	DOI
2012-07	Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer Han, Sae-Won; Cha, Yongjun; Paquet, Agnes; Huang, Weidong; Weidler, Jodi; Lie, Yolanda; Sherwood, Thomas; Bates, Michael; Haddad, Mojgan; Park, In Hae; Oh, Do-Youn; Lee, Keun Seok; Im, Seock-Ah; Bang, Yung-Jue; Ro, Jungsil; Kim, Tae-You PLoS ONE, Vol.7 No.7, p. e0039943	DOI
2012-08	Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer Park, Jinah; Park, Eunju; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo-Ho; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.4, pp.1404-1412	DOI
2012-08	ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Kim, Yu Jung; Han, Hye-Suk; Kim, Jin-Soo; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young; Bang, Yung-Jue Oncology, Vol.83 No.4, pp.218-227	DOI
2012-08	Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy Kim, N.; Park, C.; Park, D. J.; Kim, H. -H.; Kim, S.; Kim, Y. J.; Kim, J. H.; Lee, J. S.; Bang, Y. -J.; Khwarg, S. I.; Choung, H.; Lee, M. J.; Lee, K. -W. Annals of Oncology, Vol.23 No.8, pp.2065-2071	DOI
2012-08	Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon-Kyung; Chung, Doo Hyun; Yang, Seok-Chul; Kim, Young Tae; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.77 No.2, pp.460-463	DOI
2012-08	Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer Yoon, Young-Kwang; Im, Seock-Ah; Min, Ahrum; Kim, Hwang-Phill; Hur, Hyung-Seok; Lee, Kyung-Hun; Han, Sae-Won; Song, Sang-Hyun; Oh, Do Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Letters, Vol.321 No.2, pp.128-136	DOI
2012-09	Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer Bang, Yung-Jue Journal of Clinical Gastroenterology, Vol.46 No.8, pp.637-648	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
2012-09	Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.84 No.1, pp.81-87	DOI
2012-10	Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Camidge, D. Ross; Bang, Yung-Jue; Kwak, Eunice L.; Iafrate, A. John; Varella-Garcia, Marileila; Fox, Stephen B.; Riely, Gregory J.; Solomon, Benjamin; Ou, Sai-Hong I.; Kim, Dong-Wan; Salgia, Ravi; Fidias, Panagiotis; Engelman, Jeffrey A.; Gandhi, Leena; Jaenne, Pasi A.; Costa, Daniel B.; Shapiro, Geoffrey I.; LoRusso, Patricia; Ruffner, Katherine; Stephenson, Patricia; Tang, Yiyun; Wilner, Keith; Clark, Jeffrey W.; Shaw, Alice T. The Lancet Oncology, Vol.13 No.10, pp.1011-1019	DOI
2012-10	Treatment of ALK-Positive Non-Small Cell Lung Cancer Bang, Yung-Jue Archives of Pathology and Laboratory Medicine, Vol.136 No.10, pp.1201-1204	DOI
2012-11	Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancer Lutz, Manfred P.; Zalcberg, John R.; Ducreux, Michel; Ajani, Jaffer A.; Allum, William; Aust, Daniela; Bang, Yung-Jue; Cascinu, Stefano; Hoelscher, Arnulf; Jankowski, Janusz; Jansen, Edwin P. M.; Kisslich, Ralf; Lordick, Florian; Mariette, Christophe; Moehler, Markus; Oyama, Tsuneo; Roth, Arnaud; Rueschoff, Josef; Ruhstaller, Thomas; Seruca, Raquel; Stahl, Michael; Sterzing, Florian; van Cutsem, Eric; van der Gaast, Ate; van Lanschot, Jan; Ychou, Marc; Otto, Florian European Journal of Cancer, Vol.48 No.16, pp.2941-2953	DOI
2012-11	The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use Koh, Youngil; Lee, Hee Eun; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Kim, Se Hyung; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Kim, Woo-Ho; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.42 No.11, pp.1020-1027	DOI
2012-11	Adjuvant chemotherapy: An option for asian patients only? Bang, Y.-J. Recent Results in Cancer Research, Vol.196, pp.291-305	DOI
2012-12	Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung) Kim, Su-Jung; Kim, Jin Won; Oh, Do-Youn; Han, Sae-Won; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue American Journal of Clinical Oncology, Vol.35 No.6, pp.549-556	DOI

1 2 3 4 5 6 9